SEC Form 4 · accession 0001104659-26-087626
DarioHealth Corp. · DRIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Matheis
Director
Period of report
Aug 12, 2024
Accepted (ET)
Jul 28, 2026 · 5:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001533998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 12, 2024 | C | 965 | $19.10 | A | 28,596 | D | |
| Common StockF3 | Jul 23, 2026 | P | 14,430 | $6.93 | A | 43,026 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B-2 Preferred Stock | $1,000.00 | Aug 12, 2024 | C | 50 | D | May 4, 2023 | Aug 4, 2024 | Common Stock | 965 | 0 | D |
Explanation of responses
- F1Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
- F2The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion.
- F3The reported shares were acquired pursuant to a Securities Purchase Agreement with the issuer, dated July 22, 2026, at a purchase price of $6.93 per share.